Cargando…
Active surveillance for low-risk prostate cancer
Active surveillance for localized prostate cancer entails initial expectant management rather than immediate therapy, with “curative-intent” treatment deferred until there is evidence that the patient is at increased risk for disease progression. This is a response to the clearly documented risks of...
Autor principal: | Klotz, Laurence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412317/ https://www.ncbi.nlm.nih.gov/pubmed/22891078 http://dx.doi.org/10.3410/M4-16 |
Ejemplares similares
-
Active surveillance and focal therapy for low-intermediate risk prostate cancer
por: Klotz, Laurence
Publicado: (2015) -
Contemporary approach to active surveillance for favorable risk prostate cancer
por: Klotz, Laurence
Publicado: (2019) -
Active Surveillance for Favorable-Risk Prostate Cancer: A Short Review
por: Lawrentschuk, Nathan, et al.
Publicado: (2010) -
Active Surveillance for Intermediate Risk Prostate Cancer
por: Dall'Era, Marc A., et al.
Publicado: (2016) -
Active surveillance for low-risk prostate cancer – in pursuit of a standardized protocol
por: Sosnowski, Roman, et al.
Publicado: (2020)